以及世界各地人们的舒适Under our management philosophy, "Dragon Group Group is committed to creating new value through the pursuit of progress in life science and technology, and contributing to the health and well-being of people all over the world." We continue to research and develop to discover New drugs to address unmet medical needs, taking advantage of the most advanced biotechnologies in four key areas of oncology, nephrology, immunology / allergy and neurology.
As a Japanese R & D life sciences company with biopharmaceuticals as its core, Longhua has been focusing on in-house pharmaceutical R & D and manufacturing, and for the past 30 years, we have been committed to open innovation cooperation with academia. All our efforts have led to the birth of three antibody drugs, which are now available to patients worldwide. We will continue to organically combine revolutionary new medicines with internal company expertise and technology.